Diagnosis of latent tuberculosis infection in candidates for kidney transplantation (comparison of two tests)

Acta Medica Iranica

Volumn 50, Issue 5, 2012, Pages 305-310

  Ahmadinejad, Zahra ^a   Ardalan, Farid Azmoudeh ^a   Safy, Sepideh ^a   Nikbakht, Gordafarin ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Kidney transplantation; Latent tuberculosis infection; Quanti FERONTB Gold in tube; Tuberculin skin test

Indexed keywords

QUANTIFERON; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BCG VACCINATION; CLINICAL ASSESSMENT; CLINICAL EVALUATION; CLINICAL FEATURE; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERFERON GAMMA RELEASE ASSAY; INTERMETHOD COMPARISON; IRAN; KIDNEY GRAFT; LATENT TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; SCREENING TEST; TUBERCULIN TEST; TUBERCULOSIS CONTROL;

ADOLESCENT; ADULT; AGED; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; IRAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; TUBERCULOSIS;

EID: 84863197882     PISSN: 00446025     EISSN: 17359694     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Basiri A, Hosseini-Moghaddam SM, Simforoosh N, Einollahi B, Hosseini M, Foirouzan A, Pourrezagholi F, Nafar M, Zargar MA, Pourmand G, Tara A, Mombeni H, Moradi MR, Afshar AT, Gholamrezaee HR, et al. The risk factors and laboratory diagnostics for post renal transplant tuberculosis: a case-control, country-wide study on definitive cases. Transpl Infect Dis 2008;10(4):231-5.
2. Lee SS, Chou KJ, Su IJ, Chen YS, Fang HC, Huang TS, Tsai HC, Wann SR, Lin HH, Liu YC. High prevalence of latent tuberculosis infection in patients in end-stage renal disease on hemodialysis: Comparison of QuantiFERONTB GOLD, ELISPOT, and tuberculin skin test. Infection 2009;37(2):96-102.
3. Seyhan EC, Sökücü S, Altin S, Günlüoǧlu G, Trablus S, Yilmaz D, Koksalan OK, Issever H. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection in hemodialysis patients. Transpl Infect Dis 2010;12(2):98-105.
4. Azarpira N, Pakfetrat M. Tuberculosis in a kidney transplant recipient diagnosed by fine needle aspiration cytology of the bone marrow. Saudi J Kidney Dis Transpl 2009;20(3):482-3.
5. World Health Organization (WHO). Global Tuberculosis control: Epidemiology, Strategy, Financing. [Internet] 2009 Mar [cited 2012 Apr 15]; Available from: http://www.who.int/tb/publications/global_report/2009/en/index.html
6. World Health Organization (WHO) Statistical Information System (WHOSIS). Statistical Information System. Core health Indicator. [Internet] 2008 [cited 2012 Apr 2012]; Available from: http://apps.who.int/whosis/database/core/core_select.cfm
7. Manuel O, Humar A, Preiksaitis J, Doucette K, Shokoples S, Peleg AY, Cobos I, Kumar D. Comparison of quantiferon-TB gold with tuberculin skin test for detecting latent tuberculosis infection prior to liver transplantation. Am J Transplant 2007;7(12):2797-801.
8. Fitzgerald DW, Sterling TR, Hass DW. Mycobacterium tuberculosis. In: Mandell GL, Bennett JE, Dolin R, editors. Mandell, Douglas, and Bennett's Principle and Practice of Infectious Disease. 7th ed. Philadelphia: Churchill Livingstone Elsevier; 2010. p. 3129-65.
9. Pai M, Zwerling A, Menzies D. Systematic review: T-cellbased assays for the diagnosis of latent tuberculosis infection: an update. Ann Intern Med 2008;149(3):177-84.
10. Malhotra KK, Parashar MK, Sharma RK, Bhuyan UN, Dash SC, Kumar R, Rana DS. Tuberculosis in maintenance haemodialysis patients. Study from an endemic area. Postgrad Med J 1981;57(670):492-8.
11. Malhotra KK, Dash SC, Dhawan IK, Bhuyan UN, Gupta A. Tuberculosis and renal transplantation: observations from an endemic area of tuberculosis. Postgrad Med J 1986;62(727):359-62.
12. Muñoz P, Rodríguez C, Bouza E. Mycobacterium tuberculosis infection in recipients of solid organ transplants. Clin Infect Dis 2005;40(4):581-7.
13. John GT, Shankar V, Abraham AM, Mukundan U, Thomas PP, Jacob CK. Risk factors for post-transplant tuberculosis. Kidney Int 2001;60(3):1148-53.
14. Habesoǧlu MA, Torun D, Demiroglu YZ, Karatasli M, Sen N, Ermis H, Ozdemir N, Eyuboglu FO. Value of the tuberculin skin test in screening for tuberculosis in dialysis patients. Transplant Proc 2007;39(4):883-6.
15. Lee SS, Chou KJ, Dou HY, Huang TS, Ni YY, Fang HC, Tsai HC, Sy CL, Chen JK, Wu KS, Wang YH, Lin HH, Chen YS. High prevalence of latent tukberculosis infection in dialysis patients using the interferon-gamma release assay and tuberculin skin test. Clin J Am Soc Nephrol 2010;5(8):1451-7.
16. Lee E, Holzman RS. Evolution and current use of the tuberculin test. Clin Infect Dis 2002;34(3):365-70.
17. Mazurek GH, Villarino ME; CDC. Guidelines for using the QuantiFERON-TB test for diagnosing latent Mycobacterium tuberculosis infection. Centers for Disease Control and Prevention. MMWR Recomm Rep 2003 31;52(RR-2):15-8.
18. Mori T. Usefulness of interferon-gamma release assays for diagnosing TB infection and problems with these assays. J Infect Chemother 2009;15(3):143-55.
19. Bacakoǧlu F, Başoǧlu OK, Cok G, Sayiner A, Ateş M. Pulmonary tuberculosis in patients with diabetes mellitus. Respiration 2001;68(6):595-600.
20. Luetkemeyer AF, Charlebois ED, Flores LL, Bangsberg DR, Deeks SG, Martin JN, Havlir DV. Comparison of an interferon-gamma release assay with tuberculin skin testing in HIV-infected individuals. Am J Respir Crit Care Med 2007;175(7):737-42.
21. Choi JC, Shin JW, Kim JY, Park IW, Choi BW, Lee MK. The effect of previous tuberculin skin test on the follow-up examination of whole-blood interferon-gamma assay in the screening for latent tuberculosis infection. Chest 2008;133(6):1415-20.
22. Ewer K, Deeks J, Alvarez L, Bryant G, Waller S, Andersen P, Monk P, Lalvani A. Comparison of T-cell-based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet 2003;361(9364):1168-73.
23. van Woerden HC, Wilkinson J, Heaven M, Merrifield J. The effect of gender, age, and geographical location on the incidence and prevalence of renal replacement therapy in Wales. BMC Nephrol 2007;8:1.
24. Winthrop KL, Nyendak M, Calvet H, Oh P, Lo M, Swarbrick G, Johnson C, Lewinsohn DA, Lewinsohn DM, Mazurek GH. Interferon-gamma release assays for diagnosing mycobacterium tuberculosis infection in renal dialysis patients. Clin J Am Soc Nephrol 2008;3(5):1357-63.
25. Triverio PA, Bridevaux PO, Roux-Lombard P, Niksic L, Rochat T, Martin PY, Saudan P, Janssens JP. Interferongamma release assays versus tuberculin skin testing for detection of latent tuberculosis in chronic haemodialysis patients. Nephrol Dial Transplant 2009;24(6):1952-6.
26. Kim EY, Lim JE, Jung JY, Son JY, Lee KJ, Yoon YW, Park BH, Moon JW, Park MS, Kim YS, Kim SK, Chang J, Kang YA. Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population. BMC Infect Dis 2009;9:207.
27. Bartalesi F, Vicidomini S, Goletti D, Fiorelli C, Fiori G, Melchiorre D, Tortoli E, Mantella A, Benucci M, Girardi E, Cerinic MM, Bartoloni A. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases. Eur Respir J 2009;33(3):586-93.